Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Scope of the Report:
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014.
In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose.
The worldwide market for Lancets is expected to grow at a CAGR of roughly 6.3% over the next five years, will reach 2730 million US$ in 2024, from 1890 million US$ in 2019, according ...
Table of Contents
1 Market Overview
1.1 Lancets Introduction
1.2 Market Analysis by Type
1.2.1 Safety Lancets
1.2.2 Homecare Lancets
1.3 Market Analysis by Applications
1.3.1 Cholesterol Tests
1.3.2 Glucose Tests
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
22.214.171.124 United States Market States and Outlook (2014-2024)
126.96.36.199 Canada Market States and Outlook (2014-2024)
188.8.131.52 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
184.108.40.206 Germany Market States and Outlook (2014-2024)
220.127.116.11 France Market States and Outlook (2014-2024)
18.104.22.168 UK Market States and Outlook (2014-2024)
22.214.171.124 Russia Market States and Outlook (2014-2024)
126.96.36.199 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japa ...